Manganese (Mn), an essential metal and nutrient, is toxic in excess. Toxicity classically results from inhalational exposures in individuals who work in industrial settings. The first known disease of inherited Mn excess, identified in 2012, is caused by mutations in the metal exporter SLC30A10 and is characterized by Mn excess, dystonia, cirrhosis, and polycythemia. To investigate the role of SLC30A10 in Mn homeostasis, we first generated whole-body Slc30a10-deficient mice, which developed severe Mn excess and impaired systemic and biliary Mn excretion. Slc30a10 localized to canalicular membranes of hepatocytes, but mice with liver Slc30a10 deficiency developed minimal Mn excess despite impaired biliary Mn excretion. Slc30a10 also localized to the apical membrane of enterocytes, but mice with Slc30a10 deficiency in small intestines developed minimal Mn excess despite impaired Mn export into the lumen of the small intestines. Finally, mice with Slc30a10 deficiency in liver and small intestines developed Mn excess that was less severe than that observed in mice with whole-body Slc30a10 deficiency, suggesting that additional sites of Slc30a10 expression contribute to Mn homeostasis. Overall, these results indicated that Slc30a10 is essential for Mn excretion by hepatocytes and enterocytes and could be an effective target for pharmacological intervention to treat Mn toxicity. qPCR; Michael Worden and the MRI facility at Brown University for assistance with imaging, and Joseph Orchardo and David Murray for assistance with metal analysis.
Introduction
Acquired from the diet, manganese (Mn) is an essential nutrient. Mn excess can lead to neurological deficits and a disease known as manganism, with psychological and motor disturbances similar but not identical to those seen in idiopathic Parkinson's disease (1, 2) . Populations at risk for Mn toxicity include patients with iron deficiency or liver cirrhosis, recipients of Mn-supplemented total parenteral nutrition, and miners and welders who inhale Mn-rich fumes and particulates (2) (3) (4) (5) . In these populations, regulation of Mn absorption from the gut is either aberrant or bypassed, or excretion of Mn by the hepatobiliary tract is impaired.
Mn levels are regulated by gastrointestinal (GI) absorption and hepatobiliary excretion. Dietary Mn may be absorbed into duodenal enterocytes by SLC11A2 (also known as divalent metal transporter 1 [DMT1]), however, in vivo data suggest that SLC11A2 is not necessary for Mn absorption (6, 7) . Mn may be exported from enterocytes into blood by the iron transporter SLC40A1 (ferroportin), however, evidence for the role of SLC40A1 in Mn homeostasis remains controversial (8) (9) (10) (11) (12) (13) (14) . The metal importer SLC39A14 (also known as ZIP14) and exporter SLC30A10 (also known as ZNT10) have been implicated in Mn transport across the intestines. In cell culture, SLC39A14 mediates basolateral-to-apical/secretory Mn transport, and deficiency in SLC39A14 enhances Mn transport in the apical-to-basolateral/absorptive direction (15) . Studies in mice with endoderm-specific Slc30a10 deficiency and mice with intestine-specific Slc39a14 deficiency suggest that intestinal Slc30a10 and Slc39a14 regulate systemic Mn levels (15, 16) . Once absorbed, Mn may be imported into cells by SLC11A2 and other transporters including SLC39A8 (also known as ZIP8), SLC39A14, and the transferrin receptor (17) . SLC39A14 is required for Mn import into the liver from blood; SLC39A8 reclaims Mn from bile into the liver (18) (19) (20) (21) . Deficiency in SLC39A14 results in systemic Mn excess, whereas deficiency in SLC39A8 results in systemic Mn deficiency. SLC30A10 is also expressed in the liver and probably contributes to Mn export from the liver into bile. Although biliary Mn excretion is hypothesized to be the main route for Mn excretion, the molecular mechanisms for Mn excretion in vivo have not yet been fully established.
The first reported inherited disease of Mn excess, SLC30A10 deficiency, was identified in 2012, offering a key opportunity to understand molecular mechanisms of Mn homeostasis (22) (23) (24) . SLC30A10 is a member of the cation diffusion facilitator superfamily of metal transporters. It is localized to the cell membrane and implicated in Mn export (25) . Patients with homozygous mutations in SLC30A10 develop cirrhosis, dystonia, polycythemia, hypermanganesemia, and brain Mn excess, without a history of environmental Mn exposure, suggesting that Mn excess is caused by mutations in SLC30A10. SNPs in SLC30A10 are associated with changes in blood and dentine Mn levels and neurological function and may influence Mn homeostasis early in development (26) (27) (28) (29) (30) , further highlighting the idea that SLC30A10 is a key determinant of body Mn levels.
Manganese (Mn), an essential metal and nutrient, is toxic in excess. Toxicity classically results from inhalational exposures in individuals who work in industrial settings. The first known disease of inherited Mn excess, identified in 2012, is caused by mutations in the metal exporter SLC30A10 and is characterized by Mn excess, dystonia, cirrhosis, and polycythemia. To investigate the role of SLC30A10 in Mn homeostasis, we first generated whole-body Slc30a10-deficient mice, which developed severe Mn excess and impaired systemic and biliary Mn excretion. Slc30a10 localized to canalicular membranes of hepatocytes, but mice with liver Slc30a10 deficiency developed minimal Mn excess despite impaired biliary Mn excretion. Slc30a10 also localized to the apical membrane of enterocytes, but mice with Slc30a10 deficiency in small intestines developed minimal Mn excess despite impaired Mn export into the lumen of the small intestines. Finally, mice with Slc30a10 deficiency in liver and small intestines developed Mn excess that was less severe than that observed in mice with whole-body Slc30a10 deficiency, suggesting that additional sites of Slc30a10 expression contribute to Mn homeostasis. Overall, these results indicated that Slc30a10 is essential for Mn excretion by hepatocytes and enterocytes and could be an effective target for pharmacological intervention to treat Mn toxicity.
which may indicate Mn accumulation, since Mn is paramagnetic. We also noted changes in iron, copper, and zinc levels in several tissues, most notably liver and blood (Supplemental Figures 2 and 3 ). We found that blood Mn levels were increased by roughly 100-fold in Slc30a10 KO/KO mice and by 2-fold in Slc30a10 +/KO mice, although the latter increase was not significant (Figure 2A ). RBC counts were increased in Slc30a10 KO/KO mice, indicative of polycythemia, as seen in patients ( Figure 2B) . Several other red cell parameters were greater in the mutant mice (Figure 2 , C-F). Thyroxine levels were unaffected in Slc30a10 KO/KO mice ( Figure 2G ). We observed that the thyroid follicle area was decreased in female Slc30a10 KO/KO mice (Figure 2 , H and I). Histology of Slc30a10 KO/KO liver, duodenum, pancreas, and spleen showed no prominent pathology (Supplemental Figure 4) . Overall, recapitulation of phenotypes of human SLC30A10 deficiency -Mn excess, polycythemia, hepatosplenomegaly, and MRI T1 hyperintensities -suggested that Slc30a10 KO/KO mice are a valid model for interrogation of the function of Slc30a10 in Mn homeostasis.
Hepatobiliary Mn excretion is increased in WT mice loaded with dietary Mn. To understand the role of Slc30a10 in Mn homeostasis, we first evaluated systemic Mn excretion in WT mice on a control Mn (10 ppm) or high-Mn (2400 ppm) diet from weaning until tissue harvesting at 8 weeks of age. We selected the high-Mn diet on the basis of studies reporting increased tissue Mn levels without apparent toxicity (18, 32) . These experiments provided a reference for Mn excretion in a mouse with functional Slc30a10 and Mn excess.
WT mice on a high-Mn diet accumulated Mn in blood, liver, bone, and other tissues ( Figure 3 , A and B). However, Mn levels were moderate compared with levels detected in Slc30a10 KO/KO mice ( Figure 1D and Figure 2A ). The high-Mn diets led to decreased liver Slc30a10 RNA levels in female mice, decreased liver Slc39a8 and Slc39a14 RNA levels in all mice, but no changes in Slc30a10, Slc39a8, or Slc39a14 RNA levels in brain or duodenum (Supplemental Figure 5 ). Slc30a10 KO/KO mice also had decreased liver Slc39a14 RNA levels and increased brain Slc39a8 RNA levels (Supplemental Figure 5 ). The significance of these expression changes is not clear at this time. Although copper and zinc levels were largely unaffected, blood and tissue iron levels were decreased in mice raised on a high-Mn diet, which most likely reflects shared mechanisms for Mn and iron absorption (Figure 3 , C-H).
To evaluate systemic Mn excretion in WT mice raised on a high-Mn diet, mice were retro-orbitally injected with 54 Mn and housed overnight in metabolic cages for collection of feces and urine. We found that fecal 54 Mn levels were elevated in WT mice on a high-Mn diet ( Figure 4A ). Urinary 54 Mn levels were minimal compared with fecal 54 Mn levels for all mice analyzed and were unaffected by diet ( Figure 4B ), a finding consistent with fecal excretion as the main route of Mn excretion. 54 Mn levels were reduced in carcass and nearly all tissues and increased in the GI contents of mice raised on a high-Mn diet (Figure 4 , C-E).
Since Mn excretion is largely attributed to hepatobiliary excretion, we next assessed biliary Mn levels in WT mice on a control or high-Mn diet using 2 approaches. First, prior to tissue harvesting from the mice described above, we collected bile for 1 hour from anesthetized mice by ligation of the common bile duct proximal to the pancreas and cannulation of the gallbladder (see Supplemental Video 1). Biliary 54 Mn levels were elevated in WT mice on Since inherited Mn-related diseases were only recently discovered, our understanding of the role of SLC30A10 in Mn homeostasis in vivo is limited. A recent study from the Mukhopadhyay group demonstrated that Slc30a10-deficient mice develop hypothyroidism secondary to Mn excess but did not explore the mechanism linking Slc30a10 deficiency to Mn excess (31) . (Hypothyroidism has not been reported in patients with SLC30A10 mutations.) Mukhopadhyay et al. also reported on endodermspecific Slc30a10-deficient mice characterized by increased Mn levels in liver and other tissues and decreased fecal Mn levels (16) . These results suggest that endoderm-derived tissues are important for Mn homeostasis and that Slc30a10 may be required for Mn excretion. However, this work did not directly measure excretion, as changes in fecal Mn levels can reflect changes in absorption and excretion. The authors also generated hepatocyte-specific Slc30a10-deficient mice, which developed a minimal phenotype, although they did not assess whether hepatobiliary Mn excretion was impaired in this model.
In this study, we investigated the role of Slc30a10 in Mn homeostasis by generating and characterizing global and tissuespecific mouse models of Slc30a10 deficiency using genetic, metabolic, dietary, and surgical approaches. First, we demonstrated that our mouse model of global Slc30a10 deficiency recapitulates key human disease phenotypes. We then confirmed that Slc30a10 is essential not only for systemic Mn excretion but specifically for hepatobiliary Mn excretion. Given that our mice with hepatocyte-specific Slc30a10 deficiency also developed a minimal phenotype, we then identified the intestines as a prominent site of Slc30a10 expression using a CRISPR-generated mouse line expressing GFP-tagged Slc30a10 from the endogenous gene. We then demonstrated that mice with hepatocyte and enterocyte Slc30a10 deficiency have moderate, but not severe, Mn excess and that enterocyte Slc30a10 deficiency impairs Mn excretion by the small intestines. Overall, our work is the first to our knowledge to establish physiologic and mechanistic roles of Slc30a10 in vivo and indicates that the regulation of Mn levels by Slc30a10 is more complicated than previously anticipated.
Results
Global Slc30a10 deficiency in mice recapitulates key disease phenotypes. To establish the role of Slc30a10 in Mn homeostasis, we generated mice with global Slc30a10 deficiency (Slc30a10 KO/KO ) by traditional gene targeting using homologous recombination to delete exon 3 and the coding region of terminal exon 4 of Slc30a10 (Supplemental Figure 1 , A and B; supplemental material available online with this article; https://doi.org/10.1172/JCI129710DS1). Given that the mutant mice did not consistently survive past 12 weeks of age (data not shown), the Slc30a10 KO/KO mice were analyzed at 8 weeks of age. Slc30a10 deficiency was confirmed in tissues known to express Slc30a10 including liver, brain, and duodenum ( Figure  1A ). Slc30a10 KO/KO mice had hepatosplenomegaly, increased brain weights, and decreased body weights ( Figure 1 , B and C). Hepatosplenomegaly has been reported in patients (22, 24) . Mn levels were increased in Slc30a10 KO/KO tissues but most notably in liver, bone, brain, and duodenum ( Figure 1D and Supplemental Figure  2A ). MRI identified T1-weighted hyperintensities in the brain, spinal cord, and abdominal regions of the mutant mice ( Figure 1E) 54 Mn and housed overnight in metabolic cages for collection of urine and feces. In contrast to increased fecal 54 Mn levels in WT mice raised on a high-Mn diet ( Figure 4A ), we observed that fecal 54 Mn levels were moderately increased in male Slc30a10 KO/KO mice and not increased in female Slc30a10 KO/KO mice ( Figure  5A ). Given the severe levels of tissue Mn excess in Slc30a10 KO/KO mice, these 54 Mn fecal levels were inappropriately low, suggesting impaired systemic excretion. Urinary 54 Mn levels a high-Mn diet ( Figure 4F ). Second, a separate set of mice were subjected to collection of nonradioactive bile followed by measurement of total biliary metal levels. In accordance with 54 Mn levels, we observed that biliary Mn levels were increased in WT mice raised on a high-Mn diet ( Figure 4G ). Although copper is also excreted through the hepatobiliary system (33), biliary copper levels were not affected by diet in female mice but were decreased in male mice raised on a high-Mn diet ( Figure 4H ). During bile collections, we also assessed bile flow rates and found that the flow rates were decreased in male but not female mice raised on a high-Mn diet ( Figure 4I ). The significance of this is not clear, but it is unlikely that decreased bile volumes contributed to the increased biliary Mn levels observed with Mn excess. Slc30a10 +/+ and Slc30a10 KO/KO mice ( Figure 5C ). When normalized to total liver Mn levels, biliary Mn levels were lower in Slc30a10 KO/KO mice, whereas biliary Mn levels in WT mice raised on a high-Mn diet remained higher than in mice raised on a control Mn diet ( Figure  5D ). Female Slc30a10 KO/KO mice had lower biliary copper levels than did Slc30a10 +/+ mice ( Figure 5E ), a phenomenon we observed in Mnloaded rats (34) . Together, these results indicate that biliary Mn levels in Slc30a10 KO/KO mice were inappropriately low, given the level of Mn excess in these mice.
were minimal compared with fecal 54 Mn levels but were increased in male Slc30a10 KO/KO mice ( Figure 5B ). A similar increase in urinary 54 Mn levels has been shown in Slc39a14deficient mice, another model of inherited Mn excess (18) . To assess biliary Mn and copper levels, bile was collected for 1 hour following bile duct ligation and gallbladder cannulation in Slc30a10 +/+ and Slc30a10 KO/KO mice. In contrast to the 800-to 2900fold difference in biliary Mn levels between WT mice raised on a control or high-Mn diet ( Figure 4G ), biliary Mn levels were similar in To further explore the effect of Slc30a10 deficiency on biliary Mn excretion, we next assessed the rate of bile synthesis and 54 Mn export into bile in Slc30a10 +/+ and Slc30a10 KO/KO mice using the surgical approach described above, with one difference. Immediately after bile duct ligation and gallbladder cannulation, we injected 54 Mn into the portal vein. We found that blood 54 Mn levels were minimal and liver 54 Mn uptake was unimpaired, indicating intact Mn uptake into liver parenchyma ( Figure 5F ). Bile flow rates were similar in female Slc30a10 +/+ and Slc30a10 KO/KO mice but were decreased in male Slc30a10 KO/KO mice ( Figure 5G ). This differed from our dietary studies, in which male mice raised on a high-Mn diet had decreased bile flow rates ( Figure 4I ). (The significance of this is unclear.) Biliary 54 Mn levels were undetectable in Slc30a10 KO/KO mice ( Figure 5H ). Overall, our analyses of biliary Mn excretion using nonradioactive and radioactive approaches indicated that Slc30a10 is essential for Mn export into bile.
Hepatocyte Slc30a10 deficiency does not recapitulate disease phenotypes. To further explore the role of Slc30a10 in hepatobi- liary excretion, we next identified hepatic cell types that express Slc30a10. Slc30a10 RNA is abundantly expressed only in parenchymal cells ( Figure 6A ). As commercial antibodies do not reliably detect endogenous mouse Slc30a10 and our attempts at producing anti-Slc30a10 antibodies were unsuccessful (data not shown), we used CRISPR/Cas9 to introduce a GFP cDNA immediately upstream of the stop codon of the Slc30a10 gene (Slc30a10 GFP/GFP ) (Supplemental Figure 1F ). We found that tissue Mn levels were similar in Slc30a10 +/+ and Slc30a10 GFP/GFP mice but were slightly increased in Slc30a10 KO/GFP mice, suggesting that the GFP allele is mildly hypomorphic ( Figure 6B ). In Slc30a10 GFP/GFP mice, liver fluorescence was most prominent in hepatocyte membranes, and the fluorescence pattern resembled staining with antibodies against MDR1, a canalicular membrane marker ( Figure 6 , C and D). This result is similar to that previously reported in cell lines (35) . Since Slc30a10 is expressed in hepatocytes and is essential for biliary Mn excretion, we hypothesized that hepatocyte Slc30a10 is essential for Mn excretion. To this end, we generated mice with hepatocyte Slc30a10 deficiency using an albumin promoter-driven Cre recombinase transgene (Slc30a10 lox/lox Alb) (Supplemental Figure 1C ). We first characterized the effect of the Slc30a10 lox allele and Alb transgene on Mn levels. Tissue Mn levels were largely similar between Slc30a10 +/+ and Slc30a10 lox/lox mice, and tissue Mn levels did not differ between Slc30a10 +/+ and Slc30a10 +/+ Alb mice (Supplemental Figure 6 , A-C). We next assessed Slc30a10 inactivation. Slc30a10 lox/lox Alb mice exhibited a decrease of Figure 6A ). Body weight and blood parameters were unaffected in Slc40a1 fl/fl Slc30a10 lox/lox Alb mice (data not shown). We observed minimal Mn excess in mutant mice bone ( Figure 7E ). Liver and female bone iron levels were slightly increased in Slc40a1 fl/fl Slc30a10 lox/lox Alb mice ( Figure 7F ), consistent with previous reports of aberrant iron levels in mice with liver Slc40a1 deficiency (37) . Overall, these data indicated that hepatocyte Slc40a1 was not compensating for hepatocyte Slc30a10 deficiency and that long-term hepatocyte-specific deficiency of both proteins results in only minimal Mn excess. Hepatocyte Slc30a10 is required for biliary Mn excretion. To further explore the minimal Slc30a10 lox/lox Alb phenotype, we assessed systemic Mn excretion in Slc30a10 lox/lox and Slc30a10 lox/lox Alb mice. Mice were retro-orbitally injected with 54 Mn and housed in metabolic cages overnight. 54 Mn was predominantly excreted via feces, and we observed no differences in fecal or urinary 54 Mn levels between Slc30a10 lox/lox and Slc30a10 lox/lox Alb mice ( Figure 8 , A and B). Prior to tissue harvesting, the mice were subjected to bile collection via gallbladder cannulation. Although liver 54 Mn levels approximately 90% in liver Slc30a10 RNA levels at 3 weeks of age, whereas Slc30a10 KO/KO mice had nearly undetectable levels at the same age (Supplemental Figure 6D) . Given this and a preliminary analysis indicating a lack of Mn excess in 2-month-old mice (data not shown), we characterized Slc30a10 lox/lox Alb mice at 4 months of age. Slc30a10 lox/lox Alb mice had liver-specific Slc30a10 deficiency but only an approximately 2-fold increase in liver Mn levels and lesser increases in Mn levels in male bone and brain ( Figure 7, A and B) , in contrast to the severe Mn excess seen in Slc30a10 KO/KO mice. Additionally, RBC levels, body size, and organ size were similar in Slc30a10 lox/lox and Slc30a10 lox/lox Alb mice (Supplemental Figure 6E and data not shown). Overall, these data indicated that Slc30a10 expression in hepatocytes of adult mice is not essential for systemic Mn homeostasis. A more prominent phenotype may have been observed in Slc30a10 lox/lox Alb mice if the Alb transgene inactivated Slc30a10 earlier in development.
Hepatocyte Slc40a1 does not compensate for hepatocyte Slc30a10 deficiency. Besides Slc30a10, Slc40a1 (ferroportin) is the only other transporter implicated in cellular Mn export in vivo (8, 13, 14) . Since Slc40a1 is expressed on the basolateral hepatocyte membrane (36), we hypothesized that hepatocyte Slc40a1 could compensate for loss of hepatocyte Slc30a10 in Slc30a10 lox/lox Alb mice by exporting Mn from the liver into blood for excretion from routes independent of the hepatobiliary system. To test this, we generated in small intestines was compensating for liver Slc30a10 defi ciency in Slc30a10 lox/lox Alb mice, we generated mice with hepatic and enterocyte Slc30a10 deficiency (Slc30a10 lox/lox Alb Vil) (Supplemental Figure 1E ). At 4 months of age, we observed that Slc30a10 expression was deficient in liver and duodenum but retained in the brains of Slc30a10 lox/lox Alb Vil mice ( Figure 10A ). Although hepatic Mn levels were lower in Slc30a10 lox/lox Alb Vil mice than in Slc30a10 KO/KO mice, duodenal Mn levels in Slc30a10 lox/lox Alb Vil mice matched those in Slc30a10 KO/KO mice ( Figure 10B ). Slc30a10 lox/lox Alb Vil mice also had increased Mn levels in other tissues and blood ( Figure 10 , C and D). Slc30a10 lox/lox Alb Vil mice had normal body weights and RBC counts (data not shown and Supplemental Figure 6E ). Whole blood copper levels did not differ significantly, whereas iron and zinc levels were elevated in Slc30a10 lox/lox Alb Vil mice (Figure 10 , E-G). These results suggested that expression of Slc30a10 in both hepatocytes and enterocytes of the small intestines contributes to the regulation of Mn levels.
enterocytes (data not shown). To determine the contribution of intestinal Slc30a10 to Mn homeostasis, we used a villin promoterdriven Cre recombinase transgene to generate mice with enterocyte-specific Slc30a10 deficiency (Slc30a10 lox/lox Vil) (Supplemental Figure 1D ). At 4 months of age, we found that tissue Mn levels were largely similar between Slc30a10 +/+ and Slc30a10 +/+ Vil mice, suggesting that the Cre transgene did not impact Mn homeostasis (Supplemental Figure 6 , A-C). qPCR confirmed Slc30a10 deficiency in small intestine and intact Slc30a10 expression in liver, brain, stomach, cecum, and large intestine ( Figure 9C ). Slc30a10 lox/lox Vil mice had normal body weights and RBC counts (data not shown and Supplemental Figure 6E ). Slc30a10 lox/lox Vil mice had increased Mn levels in liver, bone, duodenum, and male brain ( Figure 9D ). Together, these data suggested that Slc30a10 in the small intestines contributes to Mn homeostasis. Hepatocyte and enterocyte Slc30a10 both contribute to the regulation of tissue Mn levels. To determine whether Slc30a10 expression bile duct to form the HPD, which drains bile and pancreatic fluid into the small intestines.) Mice received an injection of 54 Mn via the portal vein, and then 54 Mn content in tissues and GI tract contents were assessed 1 hour later. We also performed this analysis in Slc30a10 lox/lox Vil mice without ligation and in Slc30a10 lox/lox , Slc30a10 lox/lox Alb, and Slc30a10 lox/lox Alb Vil mice with and without
Mn excretion by enterocytes in the small intestines is dependent on Slc30a10. To assess the function of Slc30a10 in enterocytes of the small intestines, we devised a surgical approach in which the hepatopancreatic duct (HPD) was ligated just proximal to its insertion into the duodenum in Slc30a10 lox/lox Vil mice. (In mice, unlike in humans, the pancreatic duct merges with the common Blood 54 Mn levels were minimal in all groups, indicating that tissue 54 Mn levels largely reflected tissue 54 Mn uptake ( Figure 11A ). HPD ligation did not have a significant effect on pancreatic 54 Mn levels in most genotypes ( Figure 11B ) but did result in bile accumulation within the gallbladder (data not shown). Liver 54 Mn levels were decreased by HPD ligation in Slc30a10 lox/lox Alb and Slc30a10 lox/lox Vil mice ( Figure 11C ). 54 Mn levels, counted in gallbladder and bile ligation. This approach was similar to that used to assess biliary Mn excretion except that the gallbladder was not cannulated and the bile duct was ligated at the hepatopancreatic ampulla, thereby blocking excretion from both the liver and pancreas. (Note that this approach would not occlude pancreatic accessory ducts that can be present in mice and drain fluid into small intestines without merging with the hepatobiliary tract; ref. 38.) Figure 11 . Slc30a10 in both hepatocytes and enterocytes contributes to the regulation of Mn levels. Slc30a10 lox/lox with or without Alb and/or Vil underwent 54 Mn/fluorescein injection via the portal vein with (+) or without (-) prior HPD ligation (Lig). Samples were collected after 1 hour. Data for females and males were pooled. Data are presented as individual values and represent the mean ± SEM. Outliers (not shown) were identified by ROUT. To compare groups with and without ligation or specific genotypes with lox/lox mice that underwent the same surgical treatment, 2-tailed P values were calculated by unpaired t test and are indicated above the brackets at the top of the panels: *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, for comparisons between mice of the same genotype with and without ligation; ## P < 0.01 and ### P < 0.001, for comparisons between the indicated mouse genotype and In addition to the sex-specific difference in thyroid follicle size in Slc30a10 +/+ versus Slc30a10 KO/KO mice, we also observed sex-specific differences in biliary copper levels and bile flow rates ( Figure 5 , E and G). Although some of this may be attributed to intra-sex variability, other studies have reported sex-specific differences in Mn levels in individuals living near ferro-Mn industries, in rats fed diets deficient or adequate in Mn, and in children with polymorphisms in Mn transporters (26, 40, 41) . More research is required to understand the impact of sex on metal homeostasis in health and disease.
As mentioned above, the goal of this study was to establish mechanisms of Mn homeostasis. Two of our findings demonstrate that Slc30a10 is essential not only for Mn excretion but specifically for export of Mn by liver into bile. First, fecal 54 Mn and total biliary Mn levels were both inappropriately low in Our data also point to Slc30a10-independent mechanisms of Mn excretion. Although the inappropriately low fecal 54 Mn levels in Slc30a10 KO/KO mice support the notion that Slc30a10 is essential for Mn homeostasis, fecal 54 Mn levels were not decreased in Slc30a10 KO/KO mice compared with fecal levels in Slc30a10 +/+ mice ( Figure 5A ). Whether these Slc30a10-independent mechanisms of fecal Mn excretion involve the Mn importer Slc39a14 or another metal transporter remains to be determined. Similarly, although the inappropriately low total biliary Mn levels in Slc30a10 KO/KO mice support the notion that Slc30a10 is essential for hepatobiliary Mn excretion, we found that total biliary Mn levels were similar between Slc30a10 +/+ and Slc30a10 KO/KO mice ( Figure 5C ). This indicates that some level of hepatobiliary Mn excretion can occur independently of Slc30a10, which may involve other metal transporters or paracellular Mn transport into bile (42, 43) .
Although Slc30a10 lox/lox Alb mice had impaired biliary Mn excretion, they only developed minimal excess tissue Mn, similar to the findings of a previous study involving Slc30a10-deficient mice (16) . One potential explanation is delayed gene inactivation (Supplemental Figure 6D) , as previously reported for the Alb transgene (44) . This implies that expression of liver Slc30a10 in developing mice plays a critical role in Mn homeostasis. Another potential explanation is compensation by Slc30a10 in another organ. The intestines, specifically the duodenum and jejunum, have been implicated in Mn excretion (45) . Our studies demonstrate that Slc30a10 expression in both hepatocytes and enterocytes of the small intestines contribute to Mn homeostasis (Figures 9-11) . Notably, Mn levels in small intestines were similar in Slc30a10 lox/lox Alb Vil and Slc30a10 KO/KO mice, but Mn levels in liver were lower in Slc30a10 lox/lox Alb Vil than in Slc30a10 KO/KO mice. This may reflect the idea that the small intestines have a much lower storage capacity for Mn than the liver. This also suggests that contained within the gallbladder, were decreased in Slc30a10 lox/lox Alb mice and male Slc30a10 lox/lox Alb Vil mice compared with Slc30a10 lox/lox mice, consistent with the essential role for Slc30a10 in biliary Mn export ( Figure 11D) . HPD ligation increased bile and gallbladder 54 Mn levels in Slc30a10 lox/lox and Slc30a10 lox/lox Vil mice ( Figure 11D ). Although direct comparisons of 54 Mn in bile and gallbladder should be made carefully between groups with and without ligation due to the differences in bile volumes within gallbladders, the large increase in bile and gallbladder 54 Mn levels observed in Slc30a10 lox/lox Vil mice is likely too large to only reflect differences in bile volume and may reflect an essential role for Slc30a10, whereby 54 Mn can be excreted by enterocytes in the small intestines. This will be explored in more detail in the discussion.
We next assessed 54 Mn levels in specific organs within the GI tract. We found that stomach 54 Mn levels were increased in Slc30a10 lox/lox Alb and Slc30a10 lox/lox Vil mice compared with levels in Slc30a10 lox/lox mice with ligation and were increased by HPD ligation in Slc30a10 lox/lox Alb and Slc30a10 lox/lox Vil mice ( Figure  11E ). 54 Mn levels in stomach contents were low or undetectable in all groups (data not shown). Ligation increased 54 Mn levels in the small intestines and decreased 54 Mn levels in small intestine contents in Slc30a10 lox/lox Vil mice (Figure 11 , F and G). As ligation would block 54 Mn excretion from liver and pancreas into small intestines, this result is consistent with a role for enterocyte Slc30a10 in Mn excretion.
Given that Slc30a10 is expressed in the epithelial lining of the cecum (Figure 9B ), we next assessed 54 Mn levels in both tissue and contents of cecum and large intestines. We observed increased, or a trend toward increased, 54 Mn levels in cecum and large intestines within most groups when comparing mice with and without ligation ( Figure 11 , H and I). 54 Mn levels in the contents of the cecum and large intestines varied largely within groups, which made interpretations difficult (data not shown). This variation may be attributed to the 1-hour time point, which may not be long enough to observe significant excretion of 54 Mn by these tissues.
Discussion
The goal of this study was to exploit Slc30a10-deficient mouse models to establish mechanisms of Mn homeostasis. Slc30a10 KO/KO mice recapitulated several disease phenotypes (Figures 1 and  2) . Although mice in another model of Slc30a10 deficiency (31) developed aberrant thyroid function, a phenotype not reported in patients, our mice exhibited a milder thyroid phenotype, with normal serum thyroxine levels and a smaller average follicle size only in females (Figure 2 , G-I). Differences in thyroid pathology between these models may be technical in origin. Whereas we deleted exon 3 (21) . With consideration of these findings, our view of the molecular basis of Mn homeostasis is as follows: Mn is absorbed through the intestinal epithelium, however the essential factors have not been identified. The iron transporters SLC11A2 and SLC40A1 may contribute to this absorption process, however data supporting a critical role are lacking (7) (8) (9) (10) (11) (12) 14) . In intestinal enterocytes, SLC39A14 at the basolateral membrane and SLC30A10 at the apical membrane limit Mn absorption and/or enhance intestinal Mn excretion (15, 16) . Once absorbed, Mn is transported to the liver for distribution to other tissues, storage, or use within liver, or excreted from the body. SLC39A14 is the primary Mn importer in the liver (18) (19) (20) , whereas our data indicate that SLC30A10 is essential for Mn excretion into bile. Once in bile, Mn can be reimported into hepatocytes by SLC39A8 (21) or transported to the small intestines, where it can either be reabsorbed through enterohepatic circulation (45) or eliminated via feces. Although the mechanisms that govern Mn homeostasis are becoming more evident, the regulatory mechanisms that ensure Mn excretion by SLC39A14 and SLC30A10 in conditions of Mn excess and Mn retention by SLC39A8 in conditions of Mn deficiency have yet to be established. Presumably, regulatory mechanisms also exist to ensure that Mn is not excreted by SLC39A14 and SLC30A10 in conditions of Mn deficiency and that Mn is not retained by SLC39A8 in conditions of Mn excess. Additionally, since deficiency in all 3 of these transporters leads to severe disease, the importance of monitoring SNPs in these genes in populations sensitive to Mn toxicity may be critical. Such populations include miners and welders exposed to Mn-rich fumes or particulates, individuals who drink water with high Mn levels, or patients who receive Mn-supplemented total parenteral nutrition.
Methods
Care and generation of mice. Mice were bred and maintained in the animal care facility at Brown University. Mice were group-housed in ventilated cage racks, maintained on a 12-hour light/12-dark cycle with controlled temperature and humidity, and provided standard chow (LabDiet 5010; 120 ppm Mn) and water ad libitum. Littermates of the same sex were randomly assigned to experimental groups.
The generation of Slc30a10 neo/neo mice was performed in the Mouse Transgenic and Gene Targeting Facility at Brown University. A targeting vector was purchased from the Knockout Mouse Project Repository at the University of California Davis. This vector carried FRT sites flanking β-gal and neomycin resistance genes inserted between Slc30a10 exons 2 and 3 and loxP sites flanking exon 3 and the coding region of exon 4. The vector was electroporated into C57BL6/NJM8. F6 ES cells. Appropriately targeted clones were screened by PCR and Southern blotting (data not shown) and microinjected into albino B6 (C57BL/6J-Tyrc-2J) blastocysts. Chimeric mice were bred with C57BL6/NJ mice (The Jackson Laboratory) to generate progeny carrying PCR-positive mutant alleles, indicative of germline transmission. Correct transgene insertion was confirmed by PCR using primer pairs flanking the FRT-loxP insertion upstream of exon 3 (5′-TCTCAT-GCTGGAGTTCTTCG-3, 5′-CAGCACTTGAGAGGCTGAGA-3′) an additional stress is required to create severe liver Mn excess. This stress could include earlier onset of hepatocyte Slc30a10 deficiency or Slc30a10 deficiency in another organ such as the cecum and/or large intestines. (The Vil transgene only inactivated Slc30a10 in small intestines; Figure 9C .) This notion is supported by the observation that depletion of Slc30a10 in the digestive system using the endoderm-specific Foxa3-Cre transgene results in comparable Mn levels to a global Slc30a10-deficient mouse in all organs except brain (16) . Since endoderm-specific Slc30a10deficient mice retain brain Slc30a10 expression, the lack of severe Mn excess in these mice suggests that brain Slc30a10 regulates Mn levels locally, not systemically (16) . However, the specific role of Slc30a10 in the brain, i.e., Mn export from distinct cell types, remains to be established.
To evaluate Mn excretion in mice with enterocyte Slc30a10 deficiency, we used a surgical approach in which the HPD duct was ligated, the portal vein was injected with 54 Mn, and tissues and contents of each GI tract region were collected 1 hour later and counted. This experiment produced several observations. First, when Slc30a10 was deficient in enterocytes, 54 Mn accumulated in the hepatobiliary tract, as evidenced by increased bile and gallbladder 54 Mn levels in ligated Slc30a10 lox/lox Vil mice ( Figure 11D ). The relatively mild increase in bile and gallbladder 54 Mn levels in Slc30a10 lox/lox mice with and without ligation suggests that when the HPD is ligated yet Slc30a10 is still expressed in other organs such as the small intestines, other routes for 54 Mn excretion can be rapidly implemented. Second, ligation in Slc30a10 lox/lox Vil mice led to decreased 54 Mn levels in the luminal contents of the small intestines ( Figure 11G ). This most likely reflects the notion that 54 Mn excretion into the lumen of the small intestines is impaired when the hepatobiliary system is acutely blocked and Slc30a10 is deficient in small intestine enterocytes. In contrast, ligation had no impact on 54 Mn levels in small intestine contents for Slc30a10 lox/lox Alb Vil mice, which we speculate may reflect the ability of these mice, which were analyzed at 4 months of age, to adapt chronically to tissue-specific Slc30a10 deficiency by recruiting other routes of 54 Mn excretion such as the cecum and large intestines. Last, although 54 Mn levels in the luminal contents of the cecum and large intestines were undetectable or erratic (data not shown), we observed increased 54 Mn levels or a trend toward increased 54 Mn levels in the cecum and large intestines following ligation in almost all genotypes ( Figure 11 , H and I). Since Slc30a10 expression in these organs is retained in Slc30a10 lox/lox Vil mice, we propose that the cecum and large intestines may contribute to fecal Mn excretion. However, the 1-hour time period used in this experiment was insufficient to observe 54 Mn excretion by these organs.
Overall, this study demonstrates that Slc30a10 is essential for hepatobiliary Mn excretion and significantly contributes to intestinal Mn excretion. Since the discovery of SLC30A10 deficiency in 2012, mutations in 2 other Mn transporters have been identified in patients with Mn-related diseases. SLC39A14 is essential for Mn import into cells. Mutations in SLC39A14 lead to severe Mn excess (46) . Slc39a14-deficient mice have increased Mn deposition in the brain leading to neurotoxic effects, with milder Mn accumulation in the liver, gallbladder, and GI tract, suggesting an impairment in systemic Mn elimination (18) (19) (20) with C57BL/6NJ mice expressing a villin promoter-driven Cre recombinase (Vil) (The Jackson Laboratory). The transgene genotype was determined through PCR assays at Transnetyx. Mice expressing Slc30a10-GFP fusions (Slc30a10 GFP/GFP ) were created by in-frame insertion of an mClover3 cDNA (AddGene) and a 3xFLAG epitope sequence immediately before the stop codon of Slc30a10. Gene editing was achieved by pronuclear injection of spCas9 mRNA (TriLink), in vitro-transcribed sgRNA, and a donor plasmid into 1-cell C57BL/6N embryos (48, 49) . Two sgRNAs (AAACAGTACTCATTTTTAGT and TCAGACATTTTGAATTGT-GT) were designed (www.benchling.com) to introduce doublestranded breaks around the Slc30a10 stop codon. The donor plasmid for homology-directed repair was constructed by assembling a 0.8-kb left homology arm, a (GGGGS) 2 linker, mClover3, another (GGGGS) 2 linker, 3xFLAG, and a 1.5-kb right homology arm into pUC57-Simple (GenScript). Founder mice were identified by long-range PCR using primer pairs with 1 primer external to the homology arms (5′-LR-PCR: 5′-CGGATCTCCCTATGTTGTCC-3′, 5′-GAACTTGTGGCCGTTTACG-3′; 3′-LR-PCR: 5′-ACAACGTT-GAGGACGGCAG-3′, 5′-CCTAGGCTCAAGCAACTCTTC-3′). Amplicons were sequenced to confirm targeting. Founder mice were bred with WT C57BL/6NJ mice for germline transmission of the targeted allele and generation of heterozygous progeny, which were bred together to generate Slc30a10 +/+ and Slc30a10 GFP/GFP mice. The genotype was confirmed using primer pairs in exon 4 flanking the insertion site (5′-AAGGGAGCAGGGACAGACTC-3′, 5′-TAGCATGCACAAG-CCCTGTA-3′) and complimentary to the mClover3 insert (5′-AAGG-GAGCAGGGACAGACTC-3′, 5′-GTCCTCCTTGAAGTCGATGC-3′).
Adult C57BL/6NJ WT mice (The Jackson Laboratory) were bred in-house and provided LabDiet 5010 chow (120 ppm Mn) and water ad libitum. The progeny were weaned onto a control Mn (10 ppm Mn, 100 ppm iron) or high-Mn (2400 ppm Mn, 100 ppm iron) diet (Envigo). Littermates of the same sex were randomly assigned to experimental groups. Mice were provided the assigned diet and water ad libitum until tissue was harvested at 8 weeks of age.
Tissue and blood harvest. Tissue and blood were harvested from Slc30a10 +/+ , Slc30a10 +/KO , Slc30a10 KO/KO , Slc30a10 GFP/GFP , and Slc30a10 KO/GFP mice at 8 weeks of age. Tissue and blood from Slc30a10 lox/lox , Slc30a10 lox/lox Alb, Slc30a10 lox/lox Vil, Slc30a10 lox/lox Alb Vil, Slc40a1 fl/fl Slc30a10 lox/lox Alb and control mice were harvested at 4 months of age. Mice were anesthetized by i.p. injection of ketamine-xylazine. Blood was collected by retro-orbital puncture using microhematocrit capillary tubes (Fisherbrand) and serum/blood collection tubes (BD Microtainer). Blood was first collected using heparinized capillary tubes into K 2 EDTA-coated collection tubes for complete blood counts (Scil VetAbcPlus). Blood was next collected using nonheparinized capillary tubes into serum collection tubes; after 30 minutes at room temperature, the tubes were centrifuged at 10,000 g for 10 minutes and supernatants flash-frozen and stored at -80°C until analysis. Additional blood was collected using heparinized capillary tubes into lithium-heparin tubes and stored at -80°C until analysis. Mice were euthanized by cervical dislocation. Tissues were collected for histological and metal, DNA, RNA, and protein analysis. Tissues for histological analysis were fixed in 10% PBS overnight and stored in 70% ethanol at 4°C until processing. (See below for details on fluorescence microscopy of Slc30a10 GFP/GFP tissues.) All other tissues were flash-frozen and stored at -80 °C until analysis. Serum thyrox-and flanking the loxP site downstream of the stop codon in exon 4 (5′-ACTGCCTCTGGCTCTCGTC-3′, 5′-TAGCATGCACAAGCCCT-GTA-3′). Mice carrying the targeted allele (Slc30a10 +/neo ) were bred with C57BL6/NJ mice expressing Flp recombinase under the direction of the β-actin promoter (The Jackson Laboratory) to generate mice with a conditional-ready (Slc30a10 +/lox ) allele in which β-gal and neomycin resistance genes were excised, leaving only loxP sites flanking exons 3 and the coding region of exon 4.
To confirm appropriate Slc30a10 modifications, frozen liver samples from Slc30a10 neo/neo and Slc30a10 lox/lox mice underwent wholegenome sequencing (GENEWIZ). Genomic DNA was extracted and analyzed by NanoDrop 2000 and Qubit dsDNA Assay. DNA was processed using the Illumina TruSeq Paired-End Sequencing workflow, with whole-genome sequencing performed on an Illumina HiSeq in high-output mode with 2 × 150 bp paired-end configuration. Adapter sequences were trimmed and low-quality bases removed from sequence ends. Raw data, with approximately 400,000,000 reads, were analyzed using Geneious 10 (Biomatters). Sequences were paired and aligned against the predicted Slc30a10 sequence using the low-sensitivity setting with up to 5 iterations. (The predicted Slc30a10 sequence was constructed from the GRCm38 assembly of the Mus musculus strain C57BL/6J [Ensembl.org] and the targeting vector sequence from the Knockout Mouse Project repository.) A consensus sequence of the alignment was generated and aligned to the predicted Slc30a10 sequence, confirming Slc30a10 neo/neo sequence fidelity except for a 1-bp deletion upstream of the start codon, a 2-bp deletion and a 1-bp insertion upstream of the lacZ gene, and a 1-bp insertion upstream of the neomycin resistance gene. This also confirmed Slc30a10 lox/lox sequence fidelity except for the same 1-bp deletion upstream of the start codon observed in Slc30a10 neo/neo . No sequence changes were noted in exons, exon-intron junctions, or loxP sequences. Raw sequence data will be provided upon request.
To generate mice with global Slc30a10 deficiency (Slc30a10 KO/KO ), Slc30a10 lox/lox mice were bred with C57BL6/NJ mice expressing a β-actin promoter-driven Cre recombinase (The Jackson Laboratory). Slc30a10 lox/lox mice carrying the transgene were bred together to generate transgene-free Slc30a10 KO/KO mice. The presence of the Slc30a10 lox allele was confirmed using a forward primer (5′-GTGTGTGAATG-CATGGGTGT-3′) complementary to the region of intron 2 upstream of the FRT site and a reverse primer (5′-GTAGCACTGCCAGTTA-CACG-3′) located in exon 3 downstream of the FRT site. The Slc30a10 KO allele, carrying a deletion of exon 3 and the coding region of exon 4, was confirmed using a forward primer (5′-GTGTGTGAATGCATG-GGTGT-3′) complementary to the region of intron 2 upstream of the FRT site and a reverse primer (5′-TAGCATGCACAAGCCCTGTA-3′) complementary to exon 4 downstream of the loxP site.
To generate mice with hepatocyte-specific Slc30a10 deficiency (Slc30a10 lox/lox Alb), Slc30a10 lox/lox mice were bred with C57BL/6NJ mice expressing an albumin promoter-driven Cre recombinase (Alb) (The Jackson Laboratory). from the generated curve. A quality control standard (Inorganic Ventures, IV-28) was run every 10 samples to assess changes in sensitivity. If the tissue size was small or metal levels low, GF-AAS was used. Standards were measured to create a standard curve. To correct for variations in sensitivity, a quality control standard was analyzed every 10 samples (NIST, SRM 1640a). Irrespective of instrumentation, a correction curve was calculated on the basis of quality control analysis and a correction factor applied to each sample to control for changes in instrument sensitivity. Tissue microscopy. Slc30a10 +/+ and Slc30a10 GFP/GFP tissues were fixed in 4% paraformaldehyde at 4°C for 1 hour, rinsed in PBS, transferred to 15% sucrose/PBS, and incubated at 4°C for 3 to 5 hours or until the tissues sank. Tissues were transferred to 30% sucrose/PBS and incubated at 4°C as before. Tissues were embedded in OCT (Thermo Fisher Scientific) on dry ice in tissue-embedding molds (Polysciences) and stored at -80°C until sectioning. After trimming blocks at 30 μm, 8-μm sections were collected on Superfrost Plus slides (Fisherbrand) and stored at -80°C until imaging. For imaging, slides were brought to room temperature and then washed twice in PBS for 10 minutes. DAPI (0.5 mL 0.5 μg/mL) (Invitrogen, Thermo Fisher Scientific) in PBS was placed on each slide, which was then incubated in the dark at room temperature for 5 minutes. Slides were rinsed twice in PBS for 10 minutes. Imaging was performed using the EVOS FL system (Thermo Fisher Scientific).
Immunofluorescence was performed on 8-μm frozen sections. Sections were fixed in ice-cold methanol for 10 minutes followed by washing with PBS and blocking (10% goat serum, 1% BSA in PBS) for 1 hour at room temperature. Sections were incubated overnight with or without MDR1/ABCB1 antibody (Novus Biologicals, catalog NBP2-67667) in blocking buffer at 4°C without agitation. Slides were washed in PBS followed by incubation with a secondary antibody (goat antirabbit IgG, Alexa Fluor 594, Invitrogen, Thermo Fisher Scientific, catalog A-11012) in blocking buffer for 1 hour at room temperature. Slides were washed in PBS and mounted using VECTASHIELD mounting media containing DAPI (Vector Laboratories). All incubations were carried out in a humidified chamber with exposure to light minimized to avoid photobleaching.
To estimate the average thyroid follicle size, scanned images of H&E-stained thyroid were analyzed using ImageJ (NIH). Results, including all technical replicates within biological replicates, were graphed using GraphPad Prism software.
Isolation of primary hepatocytes. Hepatocytes were isolated from 8-week-old C57BL/6J female mice (50) . The portal vein was catheterized in an anesthetized mouse. The liver was perfused with 10 mL perfusion buffer (HBSS, 5 mM HEPES, 0.5 mM EDTA) and 10 mL collagenase solution (HBSS, 5 mM HEPES, 0.5 mM CaCl 2 , 0.5 mg/mL collagenase) at 2 mL/min. Immediately after the start of perfusion, the inferior vena cava was clipped; during perfusion with collagenase, the vena cava was clamped for 10 seconds every minute. The liver was removed, gently dispersed, and then strained through a 100-μm nylon strainer. The strained cell suspension was centrifuged at 50 g for 3 minutes. The pellet was resuspended in 40% Percoll and centrifuged at 200 g for 5 minutes at 4°C to pellet viable hepatocytes. The supernatant was centrifuged at 500 g for 5 minutes at 4°C, then the pellet was resuspended in PBS, 1 mM EDTA, and 2% FBS, mixed with an equal volume of 40% iodixanol, overlaid with PBS, 1 mM EDTA, and 2% FBS, and then centrifuged at 1500 g for 25 minutes. Nonparenchymal cells were taken from the interface and pelleted at 500 g for 4 minutes at 4°C. ine levels were measured using T4 ELISA (Life Technologies, Thermo Fisher Scientific).
MRI. Mice were fasted for 4 hours prior to imaging to clear GI tract contents. T 1 -weighted structural images were acquired using a Siemens 3 Tesla Prisma scanner. Mice were placed in a 16-channel wrist/ hand receive array. Two mice, side by side, were imaged at a time. Following scout image acquisition, a 3D T 1 -MPRAGE sequence was used for structural imaging. The field of view was 84 mm, with an in-plane reconstruction matrix of 256 × 256 producing an in-plane resolution of 330 μm. Slice thickness was 330 μm (104 slices), providing 3D isotropic resolution. The repetition time was 2700 ms, with an inversion time of 1100 ms. Echo time was 3.88 ms, and the read flip angle was 9°. The receive bandwidth was 210 Hz/pixel. Parallel imaging was performed using GRAPPA with an acceleration factor of 2. The scan time was 8 minutes 5 seconds on average. The final images were viewed using OsiriX Lite (Pixmeo).
RNA analysis. Tissue (100-200 mg) was homogenized in TRIzol (Invitrogen, Thermo Fisher Scientific) using 0.5 mm RNase-free zirconium beads and a Bullet Blender (Next Advance). Samples underwent chloroform extraction, isopropanol precipitation, a 70% ethanol wash, and pellet resuspension in RNase-free water, as recommended by the TRIzol protocol. RNA concentrations and A260:A280 ratio were measured using NanoDrop (Thermo Fisher Scientific).
For most RNA analyses, the following protocol was used. Standards were made by serially diluting mixtures of control and experimental samples, and then processed identically as experimental samples. Samples underwent DNase treatment and cDNA synthesis using the High Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Life Technologies, Thermo Fisher Scientific). qPCR was performed using PowerUP SYBR Green Master Mix (Thermo Fisher Scientific). The following primer pairs were used: Hprt1 (5′-GCCCCAAAATGGTTAAGGTT-3′, 5′-TGGCAACATCAACAG-GACTC-3′, spanning exons 6-9); Slc30a10 (5′-AGAGACTGCTGT-CATCTTGCTG-3′, 5′-TGTGCACTTCATGCACACTG-3′, spanning intron 3 between exons 3 and 4); Slc39a14 (5′-GGAACCCTCTACTC-CAACGC-3′, 5′-ATGGTTATGCCCGTGATGGT-3′, spanning exons 5-7); Slc39a8 (5′-CAACGCAAAGCCCAGTCTTT-3′, 5′-GCGTTT-GAGAAAAGAGTCCCAA-3′, spanning exons 3 and 4). Primers were designed using Primer3 and Geneious, with amplicon fidelity confirmed by Sanger sequencing. To analyze Slc40a1 fl/fl Slc30a10 lox/lox Alb tissue RNA levels, TaqMan gene expression assays and Master Mix (Thermo Fisher Scientific) were used to measure Slc30a10, Slc40a1, and Hprt1 expression. To analyze RNA levels in parenchymal and nonparenchymal liver cell populations, TaqMan assays and Master Mix were used to measure expression of Slc30a10, Slc40a1, albumin (hepatocytes), Tek (sinusoidal endothelial cells), Pdgfrb (stellate cells), and Adgre1 (Kupffer cells).
Metal measurements. Tissue (10-500 mg) was digested in 500-1000 μL 70% trace-metal-grade nitric acid (Termo Fisher Scientific) at 65°C for 2 hours and then diluted 25-fold in MilliQ water (Milli-poreSigma) and analyzed by inductively coupled plasma atomic emission spectroscopy (ICP-AES) (Thermo Fisher Scientific, iCAP 7400 DUO) or graphite furnace atomic absorbance spectroscopy (GF-AAS) (PerkinElmer, AAnalyst 600). Blood and bile were digested with 2 and 4 volumes of nitric acid, respectively. Most samples were analyzed by ICP-AES; blood and bile were analyzed by GF-AAS. For ICP-AES, a series of standards were analyzed and sample values extrapolated jci.org Volume 129 Number 12 December 2019
percentage of excretion was calculated as the sum of urinary or fecal radioactivity as the percentage of the sum of all radioactivity. Nonradioactive bile collection was performed as described above except that no 54 Mn was administered. Collected bile was stored at -20°C until further analysis.
To assess the rate of 54 Mn biliary excretion, mice were prepared for bile collection as described above. Once bile flow into the gallbladder cannula was confirmed, 0.5 μCi 54 MnCl 2 and 100 μg sodium fluorescein (MilliporeSigma) in 10 μL total volume were injected into the portal vein using a NANOFIL-10 syringe and a 35-gauge needle (World Precision Instruments). Fluorescein was included to confirm portal vein injection, common bile duct ligation, and gallbladder cannulation. Bile volume was noted every 5 minutes by observing the distance traveled by the bile fluid front in the gallbladder cannula. After 60 minutes of collection, the tubing was sectioned into 5-minute intervals, and 54 Mn levels in each section were measured. 54 Mn levels were measured in whole bodies and harvested tissues of euthanized mice after bile collection.
To determine whether Slc30a10 was required for Mn excretion by the small intestines, an approach similar to that described above to assess 54Mn biliary excretion was used except for 2 key differences. First, the bile duct was ligated at the site of the junction of the HPD with the small intestines, and second, the gallbladder was not cannulated.
Statistics. Statistical analysis was performed using GraphPad Prism 8 (GraphPad Software). Data are presented as individual values and represent the mean ± SEM. P values of less than 0.05 were considered statistically significant. To compare 2 groups, 2-tailed P values were calculated using an unpaired t test. To compare more than 2 groups, P values were calculated using 1-way ANOVA with Tukey's multiple comparisons test. To compare slopes of lines, linear regression was used. To compare thyroid follicle sizes, 2-tailed P values were calculated by nested t test. Outliers were identified using the Graph-Pad ROUT (robust regression and outlier removal) method (Q = 1%) and removed as stated in the figure legends.
Study approval. The studies were approved by the Institutional Animal Care and Use Committee of Brown University.
Contact for reagents and resource sharing. The authors are willing to distribute all materials, data sets, and protocols. The corresponding author holds responsibility for responding to requests and providing information regarding reagents and resource sharing. Further information and requests for resources and reagents should be directed to the corresponding author.
